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ABSTRACT
Human noroviruses (huNoVs) recognize histo-blood
group antigens (HBGAs) as attachment factors, in which
genogroup (G) I and GII huNoVs use distinct binding
interfaces. The genetic and evolutionary relationships of
GII huNoVs under selection by the host HBGAs have
been well elucidated via a number of structural studies;
however, such relationships among GI NoVs remain less
clear due to the fact that the structures of HBGA-binding
interfaces of only three GI NoVs with similar binding
proﬁles are known. In this study the crystal structures of
the P dimers of a Lewis-binding strain, the GI.8 Boxer
virus (BV) that does not bind the A and H antigens, in
complex with the Lewis b (Leb) and Ley antigens,
respectively, were determined and compared with those
of the three previously known GI huNoVs, i.e. GI.1 Nor-
walk virus (NV), GI.2 FUV258 (FUV) and GI.7 TCH060
(TCH) that bind the A/H/Le antigens. The HBGA binding
interface of BV is composed of a conserved central
binding pocket (CBP) that interacts with the β-galactose
of the precursor, and a well-developed Le epitope-bind-
ing site formed by ﬁve amino acids, including three
consecutive residues from the long P-loop and one from
the S-loop of the P1 subdomain, a feature that was not
seen in the other GI NoVs. On the other hand, the H
epitope/acetamido binding site observed in the other GI
NoVs is greatly degenerated in BV. These data explain
the evolutionary path of GI NoVs selected by the poly-
morphic human HBGAs. While the CBP is conserved,
the regions surrounding the CBP are ﬂexible, providing
freedom for changes. The loss or degeneration of the H
epitope/acetamido binding site and the reinforcement of
the Le binding site of the GI.8 BV is a typical example of
such change selected by the host Lewis epitope.
KEYWORDS norovirus, P domain, histo-blood group
antigens (HBGAs), crystal structure, norovirus-host
interaction
INTRODUCTION
Human noroviruses (huNoVs), members of the Norovirus
genus in the family Caliciviridae, are the most important viral
pathogens of epidemic acute gastroenteritis in humans,
causing signiﬁcant morbidity and mortality worldwide. Noro-
viruses (NoVs) are non-enveloped RNA viruses covered by a
protein capsid that encapsulates a single-stranded, positive-
sense RNA genome of ∼7.5 kb, encoding six functional and
two structural proteins. NoVs are genetically diverse, com-
prising of six genogroups (GI to GVI) and over 35 genetic
clusters or genotypes (Zheng et al., 2006), in which GI and
GII constitute the majority of huNoVs. Structurally, NoV
capsids exhibit a T = 3 icosahedron formed by 180 VP1s, the
single major structure protein, organized into 90 dimers. NoV
VP1 has two principle domains, the shell (S) and the pro-
truding (P) domains, linked by a short, ﬂexible hinge. The S
domain builds the interior shell that forms the basic structure
of the icosahedral capsid (Prasad et al., 1999), while the P
domain dimerizes constituting the arch-like protrusions
extending from the shell. The P dimer protrusions contain
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variable sequences and play an important role in virus-host
interaction and immune responses of NoVs.
HuNoVs recognize histo-blood group antigens (HBGAs) as
attachment factors or receptors which play an important role in
thehost susceptibility tohuNoV infections.HBGAsare complex
carbohydrates with speciﬁc oligosaccharide sequences as
determinants of blood types, including A/B/O, secretor (H), and
Lewis (Le) or non-secretor types (H negative). In addition to red
blood cells, HBGAs distribute extensively onmucosal epithelia
of intestinal tract, where they serve as attachment factors for
huNoVs to initiate an infection (Tan and Jiang, 2014, 2011,
2010). HBGAs are also presented in saliva and mother milk,
providing convenient reagents for in vitro study of huNoV-
HBGA interactions. HuNoVs interact with HBGAs in strain-
speciﬁcmannersandcomplex interactionpatternsbetween the
diverse NoVs and the polymorphic HBGAs have been descri-
bed (Huangetal., 2003, 2005).The roleofhumanHBGAs in the
host susceptibility or resistance to huNoV has been demon-
strated by human challenge studies of both GI and GII NoVs
(Frencket al., 2012;Hutsonet al., 2002; Lindesmithet al., 2003)
and by investigations of outbreaks caused by NoVs (Nordgren
et al., 2013; Tan et al., 2008).
HuNoVs are difﬁcult to study due to the lack of a cell
culture system and a small animal model. As a result, study
of huNoV-host interactions relies on the recombinant virus-
like particles (VLPs) and other subviral particles that self-
assemble through expression of the VP1 and its subdo-
mains. Earlier studies mapped the HBGA binding interfaces
in the P domain (Tan et al., 2004, 2008) that formed P dimers
(Tan et al., 2004) and/or P particles (Tan et al., 2008, 2011;
Tan and Jiang, 2005), when the P domain is expressed in
E. coli. X-ray crystallography of NoV P dimers in complex
with HBGA oligosaccharides further elucidated the struc-
tures of the HBGA-binding interfaces in atomic resolution
(Bu et al., 2008; Cao et al., 2007; Chen et al., 2011; Choi
et al., 2008; Hansman et al., 2011; Kubota et al., 2012;
Shanker et al., 2011). The conformational HBGA binding
interfaces, formed by several scattered amino acids of the P
domain, are located on the top of the arch-shaped P dimers,
corresponding to the outermost surface of the viral capsid.
Interaction networks between the terminal saccharides of
HBGAs and the amino acids forming the binding interfaces
have been thoroughly described [reviewed in (Tan and Jiang,
2014, 2011, 2010)]. While the locations and the major amino
acids that form the core structure of the HBGA binding
interfaces are apparently conserved among different geno-
types within GI and GII NoVs, the two genogroups use
completely different HBGA binding sites in interacting with
the same repertoire of human HBGAs, indicating distinct
evolution paths of the two genogroups of huNoVs.
The structural basis of GII NoV-HBGA interactions has
been thoroughly elucidated through studies of the HBGA-
binding interfaces of ﬁve GII NoVs, representing different
genetic backgrounds (GII.4 1997 variant, GII.4 2004 variant,
GII.9, GII.10 and GII.12) and various HBGA binding proﬁles
(A, B, H, Le and nonsecretor) (Cao et al., 2007; Chen et al.,
2011; Choi et al., 2008; Hansman et al., 2011; Shanker et al.,
2011). All these GII NoVs interact with variable HBGAs
through a conserved binding interface. A highly conserved
fucose (Fuc)-binding pocket at the center of the binding
interface is identiﬁed as central binding pocket (CBP) that
plays a major role in interaction with HBGAs via the α-1,2
Fuc or α-1,3/4 Fuc as the major binding saccharides
(MaBSs) (Tan and Jiang, 2014). In addition, one or two other
adjacent saccharides also participate in binding to the sur-
rounding regions of the CBP as minor binding saccharides
(MiBS) to strengthen the binding forces. Thus, a successful
binding of a GII NoV with an HBGA requires synergetic
actions of both the CBP and the surrounding region with the
MaBS and MiBSs, respectively. The relative conservation of
the CBP and the variation in the surrounding region
explained the genetic relatedness or evolutionary paths
among NoVs within a genogroup selected by the polymor-
phic human HBGAs (Tan and Jiang, 2014).
However, our understanding of GI NoV-HBGA interactions
remains limited due to the fact that the HBGA binding inter-
faces of only three GI NoVs, the Norwalk virus (NV, GI.1),
FUV258 (FUV, GI.2) and TCH060 (TCH, GI.7) are known and
the three NoVs revealed similar HBGA binding proﬁles to A/H/
Le antigen (Bu et al., 2008; Choi et al., 2008; Kubota et al.,
2012; Shanker et al., 2014), although NV binds only secretor
(Leb/y) but not nonsecretor (Lea/x) Le antigen. However, GI
NoVs are diverse in recognizing different HBGAs. The avail-
able structural data suggested that the galatose (Gal) binding
site that interact with the β-1,3Gal of the precursor or the α-1,3
Gal of the A-epitope, plays a central role in binding to various
HBGAs (Bu et al., 2008; Choi et al., 2008), while the α-1,2 Fuc
(H epitope) and α-1,3/4 Fuc (Le epitope) binding sites also
play roles in binding toH andLe antigens (Bu et al., 2008; Choi
et al., 2008; Kubota et al., 2012; Shanker et al., 2014). It
remains elusive whether the H epitope/acetamido binding site
is required for the Le binding strains that do not bind the H
antigen. To this end, we selected Boxer virus (BV), a GI.8
clinical isolate, for further structural study. Genetically, GI.8,
together with GI.9, constitutes a branch in the GI NoV phylo-
genetic tree (Fig. 1A) (Kroneman et al., 2013) and has the
longest A- and P-, but shortest T-loops (Fig. 1B) that are
heavily involved in the formation of the GI HBGA binding
interfaces (Bu et al., 2008; Choi et al., 2008; Kubota et al.,
2012; Shanker et al., 2014). UnlikeNV, FUVandTCH that bind
all A, H and Le antigens (NV binds A/H/Leb/y), BV binds only
Le, but not A and H antigens (Huang et al., 2005). Thus, BV
represents a unique model to further understand GI NoV-
HBGA interactions. Our results showed that, corresponding to
its bindingproﬁle, BVhasawell-developedLeepitope-binding
site formed by ﬁve amino acids, being the largest Le epitope
binding site of GI NoVs. On the other hand, the H epitope/
acetamido-binding site observed in the other three GI NoVs is
missing, explaining the inability of BV binding to A and H
antigens. Our data emphasize the complexity of NoV-HBGA
interactions and highlight the role of human HBGAs in the
evolution of HBGA binding interfaces of NoVs.
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Figure 1. Phylogeny of Boxer virus among GI NoVs and sequence alignment analyses. (A) Phylogenic tree of the nine knownGI
genotypeswith indications of Norwalk virus (GI.1), FUV258 (GI.2), TCH060 (GI.7), and Boxer virus (GI.8) whose crystal structures of the
HBGA-binding interfaces have been determined. (B) Sequence alignments of partial P domains of representatives of the nine knownGI
genotypes. GI.1 NV, the prototype Norwalk virus (M87661); GI.2 FUV (BAC05516); GI.3 DSV, Desert Shield virus (AAA16285); GI.4
Chiba, Chiba virus (BAB18267); GI.5 Musgro, Musgrove virus (AJ277614); GI.6 Wiscon, Wisconsin virus (AY502008); GI.7 TCH,
TCH060 (AEQ77282); GI.8 Boxer, Boxer virus (AF538679); andGI.9 Lilla, Lilla Edet virus (AEY77023). The ﬁve surface loops (A-, B-, P-,
S-, and T-loops) and U-loop are shown by rectangular frames. The residues that form the galactose-, H epitope/acetamido- and Le
epitope-binding sites of the HBGA binding interface are indicated by red, green and blue circles, respectively.
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Production, characterization and crystallization of BV P
protein
Previous results showed that the GI.8 BV, a clinical isolate,
bound uniquely to the Le, but not the A and H antigens
(Huang et al., 2005), making the BV distinct from other tes-
ted GI NoVs that bind generally the A and H antigens (Shi-
rato et al., 2008). Further sequence analysis revealed that
GI.8, together with GI.9, forms a branch in the GI phyloge-
netic tree (Fig. 1A) (Kroneman et al., 2013) that has the
longest A-, B- and P-, but the shortest S- and T-loops among
the nine genotypes of GI NoVs (Fig. 1B). These different
surface loops may be translated into distinct surface topol-
ogy of BV compared with other GI NoVs and the P- and
T-loops have been known to be heavily involved in the for-
mation of the GI HBGA binding interfaces (Bu et al., 2008;
Choi et al., 2008; Kubota et al., 2012; Shanker et al., 2014).
The BV P domain was ﬁrst expressed as P particles (Tan
and Jiang, 2005; Tan et al., 2009) to conﬁrm its HBGA
binding pattern. This revealed a typical BV binding proﬁle to
Le antigens, including the secretor Leb and Ley, as well as
the nonsecretor Lea, but not to A and H antigens (Huang
et al., 2005). P dimer was then produced in E. coli at a yield
of ∼5 mg per liter culture. The puriﬁed and concentrated P
dimer protein (>95% purity, 10 mg/mL) was crystallized in
native form and in complex with Leb and Ley tetrasaccha-
rides. The resulting crystals could diffract to high resolution
beyond 1.6 angstrom (Å). The diffraction data were collected
at synchrotron radiation centers and the structures were
solved by molecular replacement method.
The crystal structure of the native BV P domain
The native BV P protein was crystallized under the space
group of P61, containing two P protein protomers in an
asymmetric unit, related by a non-crystallographic 2-fold
axis. Peptide chain ranging from K230 to L526 (Fig. 2A) can
be modeled, while distal parts of two loop regions in the P1
subdomain (see below) comprising Q260/N261 and G502/
G503, respectively, could not be modeled due to un-inter-
pretable local electron density maps. These regions still
couldn’t be modeled in Leb or Ley complex structures, indi-
cating internal ﬂexibility properties of these regions.
BV P domain retains the basic structures of the GI NoV P
domains (Fig. 2) (Bu et al., 2008; Choi et al., 2008; Kubota
et al., 2012; Shanker et al., 2014). The P1 subdomain,
constituted by the N′ (K230–A279) and C′ (A420–L526) ter-
minal regions, forms mainly the legs of the arch-like P dimer
(see below), while the P2 subdomain, formed by a large
insertion from R280 to L419, builds the majority of the head
of the P dimer (Fig. 2B). The P1 subdomain is a mixed α/β
structure containing an amphiphile α helix and two twisted
antiparallel β sheets: β1-β9-β10 and β9-β11-β12-β13-β14,
where β9 strand was shared between the two β sheets
(Fig. 2A). The P2 subdomain is constituted mainly by a β-
barrel structure formed by two twisted antiparallel β sheets:
β5-β4-β8 and β8-β2-β3-β7-β6. Superimposing BV P domain
with the three GI homologs, GI.1 NV (Bu et al., 2008; Choi
et al., 2008), GI.2 FUV (Kubota et al., 2012) and GI.7 TCH
(Shanker et al., 2014) reveals that the P1 subdomain is very
conserved among the four structures (r.m.s.d. = 0.74 Å
compared with NV Cα atoms, r.m.s.d. = 0.71 Å compared
with FUV, and r.m.s.d. = 0.95 Å compared with TCH)
(Fig. 2C).
The major structural differences among the four P
domains reside on 6 loop regions (Figs. 2D and 3), including
the previously identiﬁed A-, B-, P-, T- and U-loops in the P2
subdomain and the S-loop in the P1 subdomain (Kubota
et al., 2012; Shanker et al., 2014), consistent with the vari-
ations, insertions and/or deletions of the sequences of the
loops (Fig. 1). It was noted that, although the U-loop shares
the same length, it shows striking structural differences
among the four strains, indicating both length and sequen-
ces determine the structures of the loops. These variable
loops have conferred BV unique surface topology differing
from the other three GI NoVs (see below).
The structure of the BV P dimer
As expected, the P protein is dimerized via a non-crystallo-
graphic 2-fold axis, forming an arch-like P dimer (Fig. 2B) in
dimension of 54 Å × 62 Å × 67 Å. The P dimer is stabilized by
the vast monomer buried surface area of 3,733 Å2 (including
two monomers) comprised of both hydrophobic and hydro-
philic residue interactions contributed from both P1 and P2
subdomains. The ﬁve loops (A-, B-, P- S- and T-loops, Fig. 1)
occupy the majority of the top surface of the BV P dimer
(Fig. 3). Corresponding to their maximum lengths, both A-
and B-loops of BV are more exposed than those of GI.1 NV,
GI.2 FUV and GI.7 TCH (Figs. 3 and 4). In addition, the two
P-loops of a P dimer that are the major components of the Le
epitope binding sites (see below) are closer to each other in
GI.1 NV, occupying the central area of the top surface of the
P dimer. They move sideward in the other three GI NoVs
(FUV, TCH and BV) forming the Le epitope binding sites,
which reach to maximum extension to the HBGA binding site
in BV (Fig. 4) (Kubota et al., 2012; Shanker et al., 2014). In
contrast, the S- and T-loops become shorter and less
exposed in BV compared with other three GI counterparts.
Therefore, the ﬁve loops with different lengths and sequence
variations change heavily the surface topologies of the P
dimers, which may be further translated into different anti-
genic features of the GI NoVs.
The HBGA binding interface of BV
The BV P dimers in complex with type 1 Leb and type 2 Ley
tetrasaccharides, respectively, were crystallized in the same
space group and unit cell dimension of native protein
(Table 1) and thus may be viewed as isomorphous with the
native crystal. Fourier difference maps were calculated from
RESEARCH ARTICLE Ning Hao et al.









diffraction intensity Fcomplex − Fnative combined with phase
angle derived from ﬁnal native protein structure, which
unambiguously reveals the high resolution electron density
maps of the bound tetrasaccharides (Fig. 5A). The structure
of tetrasaccharides were modeled and optimized by the
guidance of electron density maps and stereo-chemical
restraints. Statistics of the ﬁnal optimized complex structures
are summarized in Table 2 and torsion angles φ and ψ of the
ﬁnal tetrasaccharides are included in Table 3.
Two symmetric HBGA binding interfaces are identiﬁed on
the top of the BV P dimer at the common boundary between
the two P monomers (Fig. 5), sharing similar locations with
the other three known GI binding interfaces (Bu et al., 2008;
Choi et al., 2008; Kubota et al., 2012; Shanker et al., 2014)
(Fig. 7). The conformational binding interface of BV is com-
posed of two major areas, a β-Gal binding site and a Le
epitope binding site, formed by ten amino acids from 3 (P-,




























Figure 2. Structures of Boxer virus (BV) P domain and its comparison with those of other GI P domains. (A) Structures of the
BV P domain monomer (ribbon model). (B) Structures of the BV P domain dimer (ribbon model). The dashed lines show the boundary
between the P2 (up region) and the P1 (down region) subdomains. (C) Superimposes of the BV P domain monomer (BV, GI.8, cyan)
with those of Norwalk virus (NV, GI.1, yellow), FUV258 (FUV, GI.2, pink) and TCH060 (TCH, GI.7, dark purple) (all ribbon models).
(D) An enlargement of the top region of the superimpose [blue dashed rectangular region in (C)] of the P domains. The six surface
loops (A-, B-, P-, S, T- and U-loops) are indicated.
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and V442 form the bottom of the pocket-like binding inter-
face, while T397 and N395 forms a “wall”, and S346′, T347′,
G348′ and D349′ of the P-loop from the other protomer
formed the other “wall” of the pocket (Figs. 6 and 7). Note-
worthy, only two (D332 and S394) of these amino acids are
conserved among GI NoVs (Fig. 1B) and both residues are
components of the β-Gal binding site (see below). BV binds
the Le antigens mainly through two saccharides. The β-Gal
of the precursor makes a major contact with the “bottom” of
the binding interface, which is stabilized by residue T397,
while the Le epitope, the α-1,3/4 Fuc (Le Fuc), contacts with
another part of the “bottom” and is stabilized by the other
“wall” (S346′, T347′, G348′ and D349′) to support the binding
outcomes (Figs. 5D, 6 and 7D). Extensive hydrogen
(H) bond networks are seen between the two saccharides
and the amino acid residues of the binding interface, in
which some interactions are mediated by water molecules
(Fig. 6).
The β-Gal binding sites
This is formed by four residues from a single P monomer,
including two highly conserved (D332 and S394) and two
variable (N395 and T397) residues (Figs. 1, 5D and 6). It
interacts with the β-Gal of the precursor disaccharides
through ﬁve H bonds, including a water-bridged hydrogen
bond. This β-Gal binding site is conserved among all BV, NV,
FUV and TCH with known crystal structures (Bu et al., 2008;
Choi et al., 2008; Kubota et al., 2012; Shanker et al., 2014)
and thus may be deﬁned as the central binding pocket (CBP)
of GI HBGA binding interfaces, because it plays the central
role in GI NoV-HBGA interactions, as proposed previously
A-loop B-loop P-loop
U-loopT-loopS-loop
NV: yellow; FUV: red; BV: cyan; TCH: purple 
A B C
D E F
Figure 3. Comparisons of the structures of the six surface loops of Boxer virus (BV, GI.8, cyan) individually with those of
Norwalk virus (NV, GI.1, yellow), FUV258 (FUV, GI.2, pink) and TCH060 (TCH, GI.7, dark purple) (all ribbon models) through
superimpose approach. (A) A-loop; (B) B-loop; (C) P-loop; (D) S-loop; (E) T-loop; (F) U-loop.


















































Figure 4. Comparisons of the surface structures of the six loops among the P dimers (surface models) of Norwalk virus
(GI.1 NV), FUV258 (GI.2 FUV), TCH060 (GI.7 TCH) and Boxer virus (GI.8 BV). The A-, B-, P-, S-, T- and U-loop regions (surface
model) are indicated by different colors. The boundaries between the two P monomers are shown by dashed lines. The locations of
the HBGA binding interfaces are labeled by dashed circles.
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(Tan and Jiang, 2014). The conservation of the β-Gal binding
site may be a result of an evolutionary selection by HBGAs,
as a prerequisite for viral survival.
The Le epitope binding site
This is the other major area of the BV HBGA binding inter-
face. It is formed by ﬁve variable residues from both P pro-
tomers, including three consecutive amino acids (S346′,
T347′ and G348′) from the P-loop that extends from the other
protomer (symbol ′ indicates residue of the opposite P pro-
tomer), V442 from the S-loop extending from the P1 sub-
domain and N395 that also interact with the β-Gal (Figs. 1, 5,
6 and 7). This site interacts with the Le epitope through ﬁve
H bonds, including three water bridged H bonds. Thus,
unlike GI.1 NV that lacks a Le epitope binding site and GI.2
FUV/GI.7 TCH that has a Le epitope binding site formed by
one (FUV) or two (TCH) residues (Bu et al., 2008; Choi et al.,
2008; Kubota et al., 2012; Shanker et al., 2014). Noteworthy,
BV has a much larger, well-developed Le epitope binding
site. These ﬁndings explain the binding capability of GI NoVs
to Le antigens and highlight the role of HBGAs as a selection
factor in the evolution of the NoV binding interfaces.
The H epitope/acetamido binding site
Unlike the other three GI NoVs (NV, FUV and TCH) that the
H epitope, the α-1,2 Fuc (SeFuc), plays an important role in
interaction with the secretor HBGAs (Bu et al., 2008; Choi
et al., 2008; Kubota et al., 2012; Shanker et al., 2014), this
saccharide does not play a major role in BV-HBGA interac-
tion (Fig. 6). The H epitope binding sites of NV, FUV and
TCH are formed by two to ﬁve amino acids and none of
these residues interacts with the H epitope in BV (Figs. 6 and
7), except for W392 that may form a hydrophobic interaction
with the 6 methyl group of the H epitope. In fact, BV does not
form a single H bond with the H epitope in binding to the type
2 Ley antigen, while only one water mediated H epitope
between D349′ of the P-loop and the H epitope was seen in
BV binding to the type 1 Leb antigen (Fig. 6). Therefore, the
H epitope binding site observed in the other three GI NoV is
missing or greatly degenerated in BV. Since the H epitope
binding site also interacts with the acetamido group when the
other three GI NoVs bind the A antigens, the loss of the H
epitope/acetamido binding site explains the lack of binding of
BV to the A and H antigens. Finally, BV also forms a water
mediated H bond with the N-acetyl glucosamine (GlcNAc) of
the precursor through T347′ of the P-loop in binding to the
Leb antigen, a scenario that has not yet been observed in the
other three GI NoVs. Above comparisons of the BV binding
interface with the other three GI NoV emphasize the con-
servation of the CBP and the variations of the other binding
sites, two features that may confer NoVs both viability and
adaptability (see Discussion).
Validation of amino acids forming the binding interface
by mutagenesis study
The wild type BV is known to bind Lea, Leb and Ley antigens
(Fig. 8A and 8C). Binding changes of the individual mutants
were determined using three saliva samples that are Lea
(Nonsec/Lea), Ley (Sec/Ley) and Leb (Sec/Leb) positive,
respectively (Fig. 8B). As expected, most single mutations
(D332A, G348A, D349A, S394A, N395A and V442A) lead to
complete or nearly complete loss of binding (Fig. 8D, 8I–J
and 8L), indicating that these residues are strictly required
for the structural and functional integrity of the HBGA binding
interface. Two mutants (S346A and T347A, Fig. 8E and 8F)
retained the same binding activity, probably because: 1) the
interacting atom oxygen (= O) of the carboxyl group of S346
is also present in the alanine; and 2) serine (S346), threonine
(T347), and alanine are tiny amino acids, sharing similar
Table 1. Data collection statistics
Parameters Native P protein Complex with Leb tetrasaccharide Complex with Ley tetrasacharide
Spacegroup P61 P61 P61
Resolution rangea 50–1.50 (1.53–1.50) 50–1.63 (1.66–1.63) 50–1.45 (1.48–1.45)
Cell dimensions (Å) a 139.9 139.9 140.4
b 139.9 139.9 140.4
c 64.7 64.8 65.0
Total no. of reﬂections 1,289,366 896,187 1,433,231
No. of unique reﬂections 115,571 90,264 129,481
Completeness (%)a 100.0 (100.0) 100.0 (100.0) 100.0 (100.0)
Redundancya 11.2 (11.0) 9.9 (8.1) 11.1 (11.0)
I/σ(I)a 42.9 (5.4) 43.2 (3.6) 27.7 (6.1)
Rmerge (%)
a,b 6.1 (45.8) 7.9 (50.3) 9.5 (47.3)
a Values in parentheses correspond to the shell of highest resolution.
b Rmerge = ∑hkl| Ii − Im | / ∑hkl < Im > , where Ii and Im are the observed and mean intensity of related reﬂections with common indices h, k, and l.
Crystal structures of GI.8 Boxer P dimers in complex with HBGAs RESEARCH ARTICLE









structures, although how the mutated alanine replaces the
function of the T347 and S346 remains to be deﬁned.
Interestingly, mutant T397A showed increased binding
activity compared with that of the wild type (Fig. 8K), prob-
ably resulting from the removal of certain structure con-
straints by replacing the bigger “wall” (T397) with a smaller
one (alanine) (see Discussion).
In addition, H334 residue that is structurally nearby the
binding pocket was also examined. H334 is a conserved
residue among GI NoVs that is involved in the formation of
the Gal binding site of the other three GI NoVs. In BV it forms
an H bond (∼ 2.8 Å) with S394 to stabilize the conformation
of the CBP. As expected, H334A mutation wiped out the
binding of the BV (Fig. 8M). Thus, mutations at residues near
the binding interface can also abolish the function of the
binding interface. Noteworthy, changes of binding patterns
through mutations of amino acids in the HBGA binding
interfaces, a phenomenon that was often seen previously
(de Rougemont et al., 2011; Kubota et al., 2012; Tan et al.,
2008, 2009), does not occur among these mutations.
DISCUSSION
Before our study, the crystal structures of the HBGA binding
interfaces of three GI NoVs, the GI.1 NV, the GI.2 FUV and
the GI.7 TCH, have been determined (Bu et al., 2008; Choi
et al., 2008; Kubota et al., 2012; Shanker et al., 2014),
providing valuable information for basic understanding of GI














Le antigen-P dimer complex (top view)
Loop P
Loop S
Le antigen-P dimer complex (side view)
A
B
Le antigen binding interfaces
D
Leb tetrasaccharide Ley tetrasaccharide
C
Figure 5. Structures of Boxer virus (BV) P dimers in complex with the Leb and Ley tetrasaccharides. (A) Fourier difference
maps of the Leb (left) and Ley (right) tetrasaccharides. The electron density maps were calculated from diffraction intensity
Fcomplex − Fnative with phase angle of native protein structure contoured at 1.6 σ (grey). (B) Structures of a BV P dimer (ribbon model)
with Leb tetrasaccharides (stick and ball model) in side (left) and top (right) views, respectively. The two P monomers are shown in
purple and cyan, respectively, while the P- and S-loops that are involved in the formation of the Le epitope binding site are in yellow
and blue. (C) Top view of the BV P dimer (surface model) with indications of the two P monomers (grey and sand, respectively), Leb
tetrasaccharide (stick model), and the amino acids forming the HBGA binding interface (cyan). (D) A close-up of the Le antigen
binding interface with indication of each amino acid component. Numbers with prime (′) indicate residues of the other P protomer. In
(C) and (D) the amino acids forming the HBGA binding interface are in cyan. The individual saccharides of the Leb/y tetrasaccharides
are shown in different colors: H epitope, pink; Gal, purple; GlcNAc, green; Le epitope, yellow. The P-loop is indicated.
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NoV-HBGA interactions. However, while these three GI
NoVs represent different genetic types, they exhibit similar
HBGA binding proﬁles to the A, H and Le antigens (Huang
et al., 2005; Kubota et al., 2012), with only difference in
binding to the non-secretor Le antigens (seLe, Lea/x).
Indeed, in spite of great differences on the surface topology
due to their sequence variations of the P domains, the three
GI NoVs share similar structural features of the HBGA
binding interfaces, including a Gal- and an H- epitope/acet-
amido binding site (Bu et al., 2008; Choi et al., 2008; Kubota
et al., 2012; Shanker et al., 2014). These two binding sites
confer the three GI NoVs a common binding capability to the
A, H and secretor Le (SeLe, Leb/y) antigens. In addition,
corresponding to the ability of FUV and TCH binding to the
seLe antigens, these two GI NoVs develop an extra Le
epitope binding site, making their binding interfaces trivalent,
interacting with the Gal, H epitope/acetamido and Le epi-
tope, respectively, while the NV binding interface is bivalent,
consisting of the Gal and the H epitope/acetamido binding
sites only.
While bindings to all A, H and Le antigens appear to be a
general feature of GI NoVs (Shirato et al., 2008), different
HBGA binding proﬁles of GI NoVs have also been observed
(Huang et al., 2005). For example, the GI.8 BV represents a
typical example of such special HBGA binding proﬁles. BV
was isolated from a NoV gastroenteritis outbreak occurred
on a battle ship of US Navy in 2001. Previous study showed
that BV VLPs bound to the Le antigens only, including the
SeLe and seLe antigens, but not to the A and the H antigens.
In addition, GI.8, together with the GI.9 NoVs constitute a
genetic branch that has the longest A-, B- and P-loops, but
the shortest S- and T-loops among GI NoVs (Fig. 1). Earlier
Table 2. Structure reﬁnement statistics
Parameters Native P protein Complex with Leb tetrasaccharide Complex with Ley tetrasacharide
No. of reﬂections in working set 109,591 85,705 122,915
No. of reﬂections in test set 5,825 4,527 6,496
Rwork
a 0.136 0.131 0.128
Rfree
a 0.163 0.167 0.150
Root mean square deviation
Bond lengths (Å) 0.006 0.006 0.009
Bond angles (º) 1.057 1.054 1.199
Average B factors (Å2)
Total 19.9 27.1 20.1
Protein 17.8 25.3 17.5
Tetrasaccharide – 28.5 26.8
Solvent 32.1 39.1 33.7
Residues in the ramachandran plot (%)
Favored 97.9 97.4 97.4
Allowed 2.1 2.6 2.6
Disallowed 0.0 0.0 0.0
a Rwork = ∑| |Fobs| − |Fcal| |/∑|Fobs|, Rfree = ∑T| |Fobs| − |Fcal| |/∑T|Fobs|, where Fobs and Fcal are observed and calculated structure factors,
respectively. For Rfree, T is a randomly selected test data set (5.0%) of total reﬂections and was set aside before structure reﬁnement.
Table 3. Torsion angles of glycosidic linkages in Leb and Ley
Tetrasaccharides Saccharides phi(Φ) Psi(Ψ)
Leb α-1,4 Fuc −70.5 (−75.2) 140.4 (141.0)
β-1,3 Gal −63.7 (−63.1) −104.9 (−104.9)
α-1,2 Fuc −73.9 (−74.4) 129.2 (131.5)
Ley α-1,3 Fuc −71.6 (−76.6) −93.7 (−99.0)
β-1,4 Gal −75.8 (−69.6) 129.7 (127.2)
α-1,2 Fuc −74.2 (−72.2) 122.9 (128.1)
a Values in parentheses correspond to the tetrasaccharide at the other binding pocket related by a non-crystallographic two fold axis in the
dimer structure.
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studies showed that the A-, P- and T-loops are involved in
the formation of the HBGA binding interfaces (Bu et al.,
2008; Choi et al., 2008; Kubota et al., 2012; Shanker et al.,
2014). Thus, the different lengths of the surface loops of BV
could be the major factors leading to the unique HBGA
binding proﬁle of BV.
In this study, the crystal structures of the BV P dimers in

































Figure 6. The interaction networks between the HBGA binding interface of boxer virus (BV) and the Le antigens. (A and B)
The Le antigen binding interface of BV in complex with Leb (A) and Ley (B) tetrasaccharides, respectively, with indication of hydrogen
bonds (dashed lines). The P dimer is shown in ribbon model in cyan and purple with indications of the amino acids (in stick model,
yellow) that interact with the Le antigens. The P-, S- and T-loops are indicated by red fonts. The Leb (A) and Ley (B) antigens are
shown in stick (grey) with indications of the β-1,3 galactose (β-Gal), the Le epitope (α-1,3/4 fucose, LeFuc), H epitope (α-1,2 fucose,
SeFuc) and N-acetyle glucoseamine (GlcNAc). (C and D) Schematic illustrations of the detail hydrogen bond (dashed lines) network
between amino acids of the binding interface and the individual saccharides of the Leb (C) and Ley (D) tetrasaccharides.
RESEARCH ARTICLE Ning Hao et al.









respectively, were resolved. The data showed that BV has a
unique HBGA binding interface consisting of two major
saccharide binding sites, each interacting with the β-1,3 Gal
and the Le epitope. The β-1,3 Gal binding site is conserved
with the other three GI NoVs, while the Le epitope binding
sites are particularly well developed, formed by ﬁve residues
and interact with Le epitope via six hydrogen (H) bonds,
highlighting the importance of the Le epitope binding site in
BV. In contrast, the H epitope/acetamido binding site that is
commonly observed in NV, FUV and TCH is missing or
greatly degenerated in BV. In fact, the H epitope of the Leb
and Ley antigens played a minor role in the binding out-
comes as it does not at all participate in binding to Ley, or
interacting with the Leb through a single H bond among the
eleven H bonds in total. These data explain why BV does not
bind to the A and H antigens.
The Gal binding site is presented in all the four GI NoVs
whose structures of the HBGA binding interfaces are known
and two of their amino acid compositions (Asp and Ser) are
conserved among GI genotypes (Figs. 1 and 6). This Gal
binding site was proposed as the central binding pocket
(CBP) of the GI binding interfaces (Tan and Jiang 2014) due
to the fact that it forms the most H bonds with the β-Gal
(being designated as the major binding saccharide, MaBS)
of the HBGAs based on the two known structures of GI.1 NV
and GI.2 FUV (Bu et al., 2008; Choi et al., 2008; Kubota
et al., 2012). The recent structural data of GI.7 TCH
(Shanker et al., 2014) and GI.8 BV (this study) support this
hypothesis. The occurrence of the Gal binding site is
apparently independent from the binding proﬁles of GI NoVs.
The conservation of the CBP suggests that the β-Gal func-
tions as a strong selection factor in the evolution of the
HBGA binding interfaces of GI NoVs, which is required for
viral survival.
In contrast to the conserved Gal binding site, the H epi-
tope/acetamido- and the Le epitope binding sites are
apparently variable and even dispensable. The H epitope/
acetamido binding site is presented in all NV, FUV and TCH
that bind A, H and SeLe antigens, in which one residue
(tryptophan, W) is conserved that interacts with the H epi-
tope or the acetamido group through hydrophic interacion
(Bu et al., 2008; Choi et al., 2008; Kubota et al., 2012;
Shanker et al., 2014). However, this site is absent or plays
only minor role in BV (see above) that does not bind the A
and H antigens. Similarly, the Le epitope binding site is
missing in NV that does not bind the seLe antigen. In FUV
and TCH that bind the A, H, SeLe and seLe antigens, all the
Gal-, H epitope/acetamido- and Le epitope-binding sites are
presented. However, their Le epitope binding sites are
formed by one or two amino acids. In contrast, the Le epitope
binding site of BV is well developed, forming by ﬁve amino
acids and interacting with the Le epitope via six H bonds.
This type of binding pattern shift from the H binding to Le
binding explain the ability of BV to bind both the SeLe and
seLe antigens through the Le epitope binding site in com-
bination with the β-Gal binding site (Fig. 6) with minor sup-
port of the H epitope, a scenario differing from NV, FUV and
TCH that heavily rely on the H epitope/acetamido binding
site (Bu et al., 2008; Choi et al., 2008; Kubota et al., 2012;
Shanker et al., 2014). In summary, unlike the Gal binding
site, the occurrence of the H epitope/acetamido and the Le
epitope binding sites are variable depending on the binding
proﬁles of the GI NoVs. In other words, the occurrence,
maintenance and development of the H epitope/acetamido






































































Figure 7. Evolutionary changes of the topologies of the HBGA binding interfaces among GI.1 Norwalk virus, GI.2 FUV, GI.7
TCH and GI.8 Boxer virus (BV). (A to D) Top views of the HBGA binding interfaces (surface models) of Norwalk virus (NV) (A), GI.2
FUV (B), GI.7 TCH (C) and GI.8 BV (D) with indications of the galactose (cyan), the H epitope/acetamido (orange) and the Le epitope
(green) binding sites. The HBGAs are shown in stick with indications of the β-1,3 galactose (β-Gal, green), the Le epitope (α-1,3/4
fucose, LeFuc) (grey), H epitope (α-1,2 fucose, SeFuc) (grey) and N-acetyle glucoseamine (GlcNAc) (grey). Residues that form each
of the HBGA binding sites are indicated. The locations of the P-loops are shown.
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and Le epitope binding sites are under selection of the A/H
and/or Le epitopes.
Structural and sequence comparisons among the four GI
P domains indicate that the P-loop provides the major
components of the Le epitope binding site (Figs. 1, 5 and 6).
GI.1 NV has the shortest P-loop that could not reach to the
Le epitope of a HBGA (Fig. 6A). In GI.2 FUV the much longer
P-loop reaches the HBGA binding interface and two residues
(G343′ and G245′) are involved in the formation of the Le
epitope binding site (Kubota et al., 2012). However, the GI.8
BV has the longest P-loop that extends fully to the binding
interface, resulting in three consecutive residues (S346′,
T347′ and G348′) forming H bonds with the Le epitope
(Figs. 1, 5 and 6). Interestingly, although GI.7 TCH has a
short P loop similar to NV (Fig. 1), the distal end (G346′) of
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epitope (Fig. 7C) (Shanker et al., 2014). Thus, both the
length and sequence compositions of the P-loop are
important in the formation of the Le epitope binding site.
Another piece of evidence in supporting this hypothesis is
the participation of V442 of the S-loop in the formation of the
Le epitope binding site. BV has the shortest S-loop among
GI NoVs, but its sequence allow a distal residue (V442)
extending from the P1 subdomain to the surface of the P
dimer forming an H bond with the Le epitope, a scenario that
is seen for the ﬁrst time. These data collectively show the
ﬂexibility of the H epitope and the Le epitope binding sites, in
contrast to the conserved Gal binding site.
Another important observation of this and a previously
study (Shanker et al., 2014) is the ﬁve surface loops with
highly variable sequences and lengths (Fig. 1). These loops
form the major structures of the top surface of the P dimers
of GI NoVs (Fig. 3). As a result, the variable sequences and
lengths of these loops lead to the changes of the major
surface conformations among GI NoVs and, in turn, the
changes of the antigenic features among the GI genotypes.
Therefore, further study of the variations of these loops is
necessary to understand the principle and trends of how
these loops change evolutionarily, which would provide
useful information for future prediction of the antigenic types.
In this context, the available structural data of the four GI
NoVs would provide useful models for such future studies.
The importance of the individual amino acids for the
structural and functional integrity of the HBGA binding
interface of BV was studied by site-directed mutagenesis.
The fact that a single residue mutation wiped out the binding
function completely indicated the requirement of the subtle
structure of the binding interface. On the other hand, two
single mutations (S346A and T347A) did not affect the
binding outcomes. Crystal structure shows that S346 inter-
acts with the Le epitope through its oxygen atom (= O) of the
carboxyl group. This backbone atom is also present in ala-
nine, which may be the reason for the unchanged binding of
the S346A mutant. In addition, both threonine (T347) and
alanine are tiny amino acids, sharing similar structures,
although they are polar and nonpolar amino acids, respec-
tively. Thus, a replacement of T347 with an alanine might not
lead to a damage of the structural integrity and the function
of the binding interface. The observed increased binding
activity of the T397A mutation (Fig. 8K), might be a result of
the removal of certain structure constraint due to the bigger
“bump” of T397 in the wild type, which was replaced with a
smaller alanine in the mutant. In fact, different replacements
of amino acids in the binding interfaces of both GI and GII
NoVs are often seen, which serve as examples of some
amino acids are replaceable in functional HBGA binding
interfaces.
In summary, we have elucidated the structures of the
HBGA binding interface of the GI.8 BV that represents a
unique evolutionary path selected by the host HBGAs. While
the ability of binding to the β-Gal through the CBP (the Gal
binding site) maintained well, the BV degenerates the H
epitope/acetamido binding site that is important in the other
GI NoVs and develops a Le epitope binding site differing
from those of the other three GI NoVs. This type of relative
conservation of the CBP and ﬂexibility of the surrounding
regions is similar to that of the GII NoVs, although GI and GII
NoVs have distinct HBGA binding interfaces. Therefore, GI
and GII NoVs maintain as two distinct genetic lineages
characterized by their conserved CBPs. Within each geno-
group further divergences in recognizing different HBGAs
occur through mutations in the ﬂexible regions surrounding
the CBP under selection by hosts. Thus both the CBP and
the ﬂexible regions are important for NoVs as a successful
human pathogen. While the CBP maintains the species, the
variable surrounding regions enable NoVs to spread to dif-
ferent human populations by adaptation. This may be the
scenario of huNoVs seen today.
MATERIALS AND METHODS
Protein cloning, expression, puriﬁcation and crystallization
The cDNA fragment encoding the P domain of BV VP1 (GI.8,
GeneBank accession No. AF538679.1), including amino acid
sequences from Q227 to 526L, was cloned into pGEX-6P-1
expression vector (GE Healthcare Life Sciences) and was
expressed in E. coli BL21 (DE3). The expression and puriﬁcation
methods were similar to those for VA207 P protein as described
previously (Chen et al., 2011). The ﬁnal puriﬁed P protein was
concentrated to 10 mg/mL and crystallized with hanging drop vapor
diffusion method by mixing equal volume of P protein with reservoir
solution containing 0.1 mol/L LiCl, 18% (w/v) PEG 3350 and 10%
(v/v) 2-Methyl-2,4-Pentanediol (MPD) at 16°C. Growth of multiple
crystal clusters could be detected in about a week and seeding
Figure 8. HBGA-binding outcomes of wild type and various
mutant P particles with single amino acid mutations in the
HBGA-binding interface of Boxer virus (BV). (A) Binding of
wild type BV P particles with a panel of oligosaccharides
representing different HBGAs (A, B H1, H2, Lea, Leb, Lex and
Ley). The positive binding of VA207 P particles with Lex antigen
(Lex-207) serves as a positive control of Lex antigen. VA207
(GII.9) is another Lewis binding NoV that has been shown to
bind Lex antigen. (B) HBGA phenotyping of saliva samples. The
three saliva samples that were used for binding with mutant P
particles (C–M) were typed phenotypically by various monoclo-
nal antibodies speciﬁc to A, B H1, H2, Lea, Leb, Lex and Ley
antigens. The concentrations of the P particles were 10 mg/mL.
(C–M) HBGA-binding outcomes of wild type (C) and various
mutant P particles with single amino acid mutations in the
HBGA-binding interface of BV (D–M) with the well-deﬁned
saliva samples. The three saliva samples were positive with
nonsecretor Lea (Nonsec/Lea), secretor Ley (Sec/Ley) and
secretor Leb (Sec/Leb), respectively. Y axes indicate the optical
densities at 450 nm (OD450), while the X-axes indicate the
concentrations of the P particles (ng/µL).
s
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technique was used for growth of single crystals qualiﬁed for data
collection. For complex crystal growth, the P protein (14 mg/mL)
was mixed with equal volume of Leb [α-Fuc-(1,2)-β-Gal-(1,3)-(α-
Fuc-(1,4))-GlcNAc] (Sigma, product number: L7659) or Ley [α-Fuc-
(1,2)-β-Gal-(1,4)-(α-Fuc-(1,3))-GlcNAc] (Sigma, product number:
L7784) tetrasaccharide to a ﬁnal molar ratio of 1:40, incubated for
1 h at 4°C and then crystallized with same reservoir solution. The
crystallization drops were seeded the next day with crushed native
protein crystals and the complex crystals could be grown within
5 days.
Data collection and processing
Native and complex crystals were harvested, brieﬂy soaked for 10 s
in cryoprotectant composed of corresponding reservoir solution plus
15% (v/v) glycerol before mounted for diffraction test and data col-
lection. The P protein native and Leb complex data were collected at
beamline 17A and 1A of Photon Factory of KEK Japan and complex
Y diffraction data were collected at beamline 17U of Shanghai
Synchrotron Radiation Facility (SSRF), all at the temperature of
100 K and wavelength of 1.0000 Å. X-ray diffraction data were
indexed, integrated and scaled by HKL2000 (Otwinowski and Minor,
1997) software package. Statistics for data collection and process-
ing are summarized in Table 1.
Structure determination and analysis
The crystal structure of Norwalk virus P protein (PDB entry: 2ZL7)
was used as the starting model by the program Phaser (McCoy
et al., 2007) to solve the phases of the Boxer P protein structure.
Due to the high resolution (∼1.6 Å) of density map, we applied
Autobuild from Phenix software package(Adams et al., 2002) to
automatically build the main P protein structure before manually
adjust the structure in COOT (Emsley and Cowtan, 2004) guided by
(2Fo - Fc) and (Fo - Fc) electron density maps, where Fo and Fc are
the observed and calculated structure factors, respectively. The
programs REFMAC(Murshudov et al., 1997) and Phenix were also
applied for further structure optimization before water molecules
were added to the (Fo - Fc) electron density map peaks (>2.5 σ)
where they could form stable hydrogen (H) bonds (2.6–3.4 Å) with
nearby amino acid residues. The ﬁnal structure of P protein was
validated with PROCHECK(Laskowski et al., 1993) prior to deposi-
tion to the PDB databank. The structures of P protein complexed
with Leb and Ley tetrasaccharides were solved with the native P
protein structure as search model, optimized and validated in similar
ways. Analyses of ﬁnal structures were performed by programs
Edpdb(Zhang and Matthews, 1995) and Pymol (DeLano Scientiﬁc
LLC).
Protein data bank deposition
The coordinates, structure factors and other related information of
the structures for native BV P protein (PDB entry: 4RDJ) and its
complexes with Leb (PDB entry: 4RDK) and Ley (PDB entry: 4RDL)
have been deposited in the Protein Data Bank, Research Collabo-
ratory for Structural Bioinformatics, Rutgers University, New Bruns-
wick, NJ, USA.
Expression and puriﬁcation of BV P particles with single mutations
Single amino acid mutations were introduced to the HBGA binding
site of the P protein of BV through site-directed mutagenesis using
the wild type construct of P domain (in plasmid pGEX-4T-1, GE
Healthcare Life Sciences) as template. Site-directed mutagenesis
was performed using the QuickChange Site-Directed Mutagenesis
Kit (Agilent Technology, CA, USA) and corresponding primer pairs
with designed mutations. The mutated P proteins were expressed
and puriﬁed by E. coli system (BL21) as P particles as described
previously (Tan et al., 2008; Tan and Jiang, 2005; Tan et al., 2009).
The GST-P domain fusion proteins were digested by thrombin to
release the P proteins that self-assembled into P particles. The P
particle formation was determined by gel ﬁltration chromatography
using a size-exclusion column Superdex 200 (GE Healthcare Life
Sciences, Piscataway, NJ) powered by an AKTA-FPLC system
(model 920, GE Healthcare Life Sciences, Piscataway, NJ) followed
by SDS-PAGE electrophoresis, in which the P particles form a peak
at 830 kDa. The efﬁciency of P particle formation was ∼80%. None
of the designed single residue mutations in this study affected the P
particle formation.
HBGA binding assays
These were performed as described elsewhere (Huang et al.,
2005). The afﬁnity-column puriﬁed BV P particles were ﬁrst diluted
to 0.2 mg/mL as starting solutions. They were then diluted further
in a 2-fold-series to indicated concentrations directly on the Elisa
plates that had been coated with saliva samples. A panel of syn-
thetic oligosaccharides representing types A, B, H1, H2, Lea, Leb,
Lex, Ley and three well-characterized saliva samples with known
HBGA phenotypes of Lea, Leb and Ley were used for the binding
assays.
HBGA phenotyping of saliva samples
This was performed by EIA assays using the corresponding mono-
clonal antibodies (Mabs) against individual HBGAs as described
previously (Huang et al., 2005; Tan et al., 2008). Brieﬂy, boiled and
diluted saliva samples were coated on microtiter plates. Corre-
sponding Mabs (1:100) against individual antigens (A, B, H1, H2,
Lea, Leb, Lex, Ley) (Signet Laboratories Inc., Dedham, MA) were
added followed by incubation with corresponding secondary anti-
body horseradish peroxidase (HRP) conjugates (Immunology Con-
sultants Laboratory Inc., Newberg, OR). The color signal was
displayed by HRP substrate reagents (optEIA, BD Bioscience, San
Diego, CA).
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BV, Boxer virus; CBP, central binding pocket; Gal, galatose;
huNoVs, human noroviruses; HBGAs, histo-blood group antigens;
MaBSs, major binding saccharides; MiBSs, minor binding
saccharides; VLPs, virus-like particles; P domain, protruding domain.
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